West Pharmaceutical Services Inc (WST)
372.07
-5.26
(-1.39%)
USD |
NYSE |
Apr 19, 16:00
368.01
-4.06
(-1.09%)
After-Hours: 20:00
West Pharmaceutical Services Enterprise Value: 26.98B for April 18, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 18, 2024 | 26.98B |
| April 17, 2024 | 26.98B |
| April 16, 2024 | 27.13B |
| April 15, 2024 | 27.08B |
| April 12, 2024 | 27.17B |
| April 11, 2024 | 27.73B |
| April 10, 2024 | 27.89B |
| April 09, 2024 | 28.08B |
| April 08, 2024 | 28.09B |
| April 05, 2024 | 28.20B |
| April 04, 2024 | 27.62B |
| April 03, 2024 | 27.69B |
| April 02, 2024 | 27.75B |
| April 01, 2024 | 28.34B |
| March 28, 2024 | 28.32B |
| March 27, 2024 | 28.20B |
| March 26, 2024 | 27.77B |
| March 25, 2024 | 27.79B |
| March 22, 2024 | 28.19B |
| March 21, 2024 | 28.33B |
| March 20, 2024 | 28.20B |
| March 19, 2024 | 28.32B |
| March 18, 2024 | 28.32B |
| March 15, 2024 | 27.73B |
| March 14, 2024 | 28.59B |
| Date | Value |
|---|---|
| March 13, 2024 | 27.59B |
| March 12, 2024 | 27.02B |
| March 11, 2024 | 25.53B |
| March 08, 2024 | 25.63B |
| March 07, 2024 | 25.86B |
| March 06, 2024 | 25.29B |
| March 05, 2024 | 25.12B |
| March 04, 2024 | 25.62B |
| March 01, 2024 | 25.61B |
| February 29, 2024 | 25.59B |
| February 28, 2024 | 25.51B |
| February 27, 2024 | 25.62B |
| February 26, 2024 | 25.98B |
| February 23, 2024 | 26.29B |
| February 22, 2024 | 25.73B |
| February 21, 2024 | 25.46B |
| February 20, 2024 | 25.02B |
| February 16, 2024 | 25.89B |
| February 15, 2024 | 25.06B |
| February 14, 2024 | 29.27B |
| February 13, 2024 | 28.57B |
| February 12, 2024 | 29.16B |
| February 09, 2024 | 29.38B |
| February 08, 2024 | 29.47B |
| February 07, 2024 | 29.63B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
8.172B
Minimum
Apr 22 2019
34.48B
Maximum
Dec 30 2021
21.20B
Average
21.86B
Median
Enterprise Value Benchmarks
| Becton Dickinson & Co | 82.29B |
| Abbott Laboratories | 190.29B |
| Masimo Corp | 7.934B |
| Merit Medical Systems Inc | 4.351B |
| Insulet Corp | 12.23B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 137.00M |
| Revenue (Quarterly) | 732.00M |
| Total Expenses (Quarterly) | 562.20M |
| EPS Diluted (Quarterly) | 1.83 |
| Gross Profit Margin (Quarterly) | 38.01% |
| Profit Margin (Quarterly) | 18.72% |
| Earnings Yield | 2.12% |
| Operating Earnings Yield | 2.53% |
| Normalized Earnings Yield | 2.210 |